표제지
목차
CPATHㆍCenter for Policy Analysis on Trade and Health 3
KOREAN TRADE AGREEMENT : THREAT TO PUBLIC HEALTH MAY 30, 2007 3
US-Korea Free Trade Agreement : Public Health Report Card 4
Public Health Objective for Global Trade # 1 : Access to Affordable Medicines 4
Public Health Objective for Global Trade # 2 : To exclude tobacco and tobacco products 8
Public Health Objective for Global Trade # 3 : Democratic Participation by Public Health and Transparency Trade Policy 10
Public Health Objective for Global Trade # 4 : To exclude tariff and nontariff provisions in trade agreements that address vital human services 12
Public Health Objective for Global Trade # 5: To recognize the legitimate exercise of national, regional and local government sovereignty to protect population health, 15
Public Health Objective for Global Trade # 6 : create sustainable economic development 17
Public Health Objective for Global Trade # 7 : To exclude alcohol products 18
Public Health Objectives for International Trade Agreements 19
The New Trade Policy for America-How Will It Affect Korea? / Mike Palmedo 21
May 10, 2007 : New Trade Policy Announced 22
Labor Chapter of the New Trade Policy for America 23
Environmental Chapter of the New Trade Policy for America 24
IPR Chapter of the New Trade Policy for America 25
Korus FTA & New Trade Policy for America s IP Guidelines 26
Data Exclusivity 27
Linkage 28
Patent Extensions 29
Second Use Patents 30
Pharmaceuticals Chapter Favors Brand Name Firms 31
Three Things to Remember 32
한미 FTA 보건의료분야 협상 1차 분석 / 우석균 34
1. 의약품 및 의료기기 협정 결과 분석 35
1) 의약품 및 의료기기 관련 협상에 대한 정부의 주장 35
2) 한미 FTA 의약품 및 의료기기 제도 협상의 문제점 (협정문 5장) 37
3) 의약품관련 지적재산권 협정의 문제점 (협정문 18.8, 18.9) 38
4) 의약품 및 의료기기 협상의 문제점 요약 40
5) 의약품 협상의 국민추가부담액 41
2. 한미 FTA와 경제자유구역 : 건강보험 예외 영리병원 허용의 고착화 42
3. 한미 FTA와 민간의료보험 규제철폐 43
4. 한미 FTA와 의료기기(CT,MRI)규제입법 포기 44
5. 한미 FTA와 식품안전정책의 포기 44
1) 미국산 쇠고기의 무조건적 수입 : 위생검역조치 포기 44
2) 유전자조작식품 규제 철폐 : GMO 위험성에 전국민 노출 45
3) 조류독감지역화 및 육류검사시스템 동등성 인정 46
6. 자동차 배기가스 규제 철폐 : 조세정책 및 환경정책 포기 46
7. 담배, 주류 관세철폐 : 금연 절주정책의 포기 47
8. 기업규제에 대한 철폐 : 기업으로부터 국민건강을 지킬 정부 권한의 포기 47
9. 결론 47
참고자료 1. 한미 FTA 협정문, 민간의료보험 부문검토 48
한미 FTA 협상 평가ㆍ지적재산권과 의약품 / 남희섭 50
1. 개괄 50
2. '허가-특허 연계(linkage)'조항의 문제점 50
2-1. 공개된 협상문의 내용과 해설 50
2-2. 정부 발표 51
2-3. 의약품 지적재산권 분야의 대표적인 독소 조항 52
2-4 .내용을 모른채 한 협상 결과 (특허소송의 경우 시판허가의 자동정지) 53
2-5. 협상 목표를 협상문에 엉뚱하게 반영한 내용 56
2-6. 피해 규모의 억지 축소 59
3. 의약품 지재권 중 '자료 독점권' 관련 조항의 문제점 62
3-1. 트립스 협정의 규정과 해석 62
3-2. 한국의 제도와 실무 64
3-3. 자료 독점권 제도의 문제점 65
3-4. 정부 주장의 문제점 66
별첨 #1. 한ㆍ미 FTA의 경제적 효과 분석(2007. 4. 27. 11개 국책연구원) 67
WHO economic model to analyze the impact of TRIPS+provisions-an introduction / Sanya Reid Smith 69
Some relevant World Health Assembly resolutions 70
WHO s Commission on Intellectual Property Rights, Innovation and Public Health : some relevant recommendations 71
Analysis possible with the WHO model 72
Application of the model to Colombia 73
The Korus FTA Will lead to Highter Drug Prices in Korea / Mike Palmedo 76
IPR Chapter of the New Trade Policy for America 77
Korus FTA & New Trade Policy for America's IP Guidelines 78
Data Exclusivity 79
Linkage 80
Patent Extensions 81
Second Use Patents 82
Pharmaceuticals and medical devices chapter attacks the negotiations for reimbursement rates 83
Scope of Medicines Section 84
Innovative or Patented 85
Transparency 86
The pharmaceuticals and medical devices chapter will affect korea, bus U.S. drug price negotiations are largely unaffected 87
Footnote 1-Excluding Military Healthcare in U.S. 88
State governments in the U.S. negotiate reimbursement rates for pharmaceuticals for poor and disabled patients through medicaid 89
State Senators Warn USTR About US-Australia FTA Threat to medicaid 90
USTR Attacks Health Reforms During Korus FTA Negotiations 91
Carve-Out for State Medicaid Programs 92
Three things to remember 93
KORUS FTA A Trade Deal That Undermines People's Health / Ellen R. Shaffer, PhD MPH;Joe Brenner, MA 95
A Great Deal for U.S. Services 96
U.S. Chamber of Commerce : OK! 97
Korean Trade Institute : Valuable Edge 98
What Is The Problem? KORUS and Health 99
Why Is This A Problem? Democracy in Trade Policy 100
U.S. Trade Advisory Committees : Big Business : 42 Public Health : 0 101
KORUS, HEALTH and RESPONSE 102
1. Access to affordable medicines 103
2. Tobacco Control 106
3. Democratic Participation by Public Health and Transparency in Trade Policy 107
4. Protect vital human services 108
5. Government sovereignty to protect population health 110
6. Sustainable economic development 111
7. Alcohol Beverage Controls 112
Agriculture, Trade and Obesity 113
Worldwide Obesity 114
Diabetes prevalence in people over 20 years of age in 2000 and predicted for 2030 115
Can Public Health Do? 116
Alternative Models 117
Health leaders Prescribe Caution on Trade Agreements 118
Getting Specific : Public Health Objectives for 2007 CPATH and Major Public Health Groups 119
Network With CPATH 122
[표 1] 한미 FTA 의약품 / 의료기기 협상의 개요 36
[표 2] 한미 FTA 의약품협상으로 인한 피해추계액 41
[그림 1] 미국의 특허소송기간 40